A Controlled Study of Short-Term Prednisone Treatment in Adults with Membranous Nephropathy: Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

New England Journal of Medicine

Volumn 301, Issue 24, 1979, Pages 1301-1306

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREDNISONE;

CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMPARISON; DRUG THERAPY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IDIOPATHIC NEPHROTIC SYNDROME; KIDNEY; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; MICROSCOPY; NEPHROTIC SYNDROME; NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; THERAPY;

ADOLESCENT; ADULT; AGED; CLINICAL TRIALS; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMAN; KIDNEY; MALE; MIDDLE AGE; NEPHROTIC SYNDROME; PREDNISONE; PROTEINURIA; RANDOM ALLOCATION; REMISSION, SPONTANEOUS; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0018629308     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197912133012401     Document Type: Article

References (29)

1. Luetscher JA Jr, Deming QB: Treatment of nephrosis with cortisone. J Clin Invest 29: 1576–1587, 1950
2. Churg J, Habib R, White RHR: Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 1: 1299–1302, 1970
3. Ehrenreich T, Churg J: Pathology of membranous nephropathy. Pathol Annu 3: 145–186, 1968
4. Cameron JS, Blandford G: The simple assessment of selectivity in heavy proteinuria. Lancet 2: 242–247, 1966
5. Mitch WE, Walser M, Buffington GA, et al: A simple method of estimating progression of chronic renal failure. Lancet 2: 1326–1328, 1976
6. Rutherford WE, Blondin J, Miller JP, et al: Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int 11: 62–70, 1977
7. Siegel S: Nonparametric Statistics for the Behavioral Sciences. New York, McGraw-Hill Book Company, 1956
8. Alder HL, Roessler EB: Introduction to Probability and Statistics. San Francisco, WH Freeman & Company, 1972
9. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34: 585–612, 1976
10. Hopper J Jr. Membranous nephropathy, relative benignity in woman. Presented at the seventh International Congress of Nephrology, Montreal, Canada, June 18–23, 1978
11. Rastogi SP, Hart-Mercer, Kerr DNS: Idiopathic membranous glomerulonephritis in adults: remission following steroid therapy. Q J Med 38: 335–350, 1969
12. Forland M, Spargo BH: Clinicopathological correlations in idiopathic nephrotic syndrome with membranous nephropathy. Nephron 6: 498–525, 1969
13. Franklin WA, Jennings RB, Earle DP: Membranous glomerulonephritis: long-term serial observations on clinical course and morphology. Kidney Int 4: 36–56, 1973
14. Hopper J Jr: Membranous glomerulonephritis. Ann Intern Med 79: 285–286, 1973
15. Ehrenreich T, Porush JG, Churg J, et al: Treatment of idiopathic membranous nephropathy. N Engl J Med 295: 741–746, 1976
16. Bolton WK, Atuk NO, Sturgill BC, et al: Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 62: 60–70,1977
17. Idelson BA, Smithline N, Smith GW, et al: Prognosis in steroid-treated idiopathic nephrotic syndrome in adults: analysis of major predictive factors after ten-year follow-up. Arch Intern Med 137: 891–896, 1977
18. Ross EJ: Effect of long-term steroid therapy in adults. Presented at the third International Congress of Nephrology, Washington, DC, September 23–30, 1966
19. Hardwicke J, Blainey JD, Brewer DB, et al: The nephrotic syndrome. Presented at the third International Congress of Nephrology, Washington, DC, September 23–30, 1966
20. Cameron JS: Histology, protein clearances, and response to treatment in the nephrotic syndrome. Br Med J 4: 352–356, 1968
21. Pollak VE, Rosen S, Pirani CL, et al: Natural history of lipoid nephrosis and membranous glomerulonephritis. Ann Intern Med 69: 1171–1196, 1968
22. Rosen S: Membranous glomerulonephritis. Hum Pathol 2: 209–231, 1971
23. Gluck MC, Gallo G, Lowenstein J, et al: Membranous glomerulonephritis. Ann Intern Med 78: 1–12, 1973
24. Hayslett JP, Kashgarian M, Bensch KG, et al: Clinicopathological correlations in the nephrotic syndrome due to primary renal disease. Medicine (Baltimore) 52: 93–120, 1973
25. Erwin DT, Donadio JV Jr, Holley KE: The clinical course of idiopathic membranous nephropathy. Mayo Clin Proc 48: 697–712, 1973
26. Row PG, Cameron JS, Turner DR, et al: Membranous nephropathy. Q J Med 44: 207–239, 1975
27. Pierides AM, Malasit P, Morley AR, et al: Idiopathic membranous nephropathy. Q J Med 46: 163–178, 1977
28. Black DAK, Rose G, Brewer DB: Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 3: 421–426, 1970
29. Moorthy AV, Zimmerman SW, Burkholder PM, et al: Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases. Clin Nephrol 6: 320–325, 1976